Liao YS et al. |
[Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts]. |
2011 |
Zhonghua Zhong Liu Za Zhi |
pmid:21575494
|
Wu WJ et al. |
[Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells]. |
2010 |
Zhonghua Gan Zang Bing Za Zhi |
pmid:20380798
|
Liu HY et al. |
[Effects of anandamide on the activation and proliferation of hepatic stellate cells through cannabinoid-2 receptors]. |
2008 |
Zhonghua Gan Zang Bing Za Zhi |
pmid:18578993
|
Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Ueda N et al. |
Alkaline and acid amidases hydrolyzing anandamide and other N-acylethanolamines. |
2001 |
World Rev Nutr Diet |
pmid:11935959
|
Hansen HS et al. |
When and where are N-acylethanolamine phospholipids and anandamide formed? |
2001 |
World Rev Nutr Diet |
pmid:11935960
|
Roser P et al. |
Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists. |
2010 |
World J. Biol. Psychiatry |
pmid:20218784
|
Okamoto Y et al. |
Enzymatic formation of anandamide. |
2009 |
Vitam. Horm. |
pmid:19647106
|
Yates ML and Barker EL |
Organized trafficking of anandamide and related lipids. |
2009 |
Vitam. Horm. |
pmid:19647107
|
Goodfellow CE and Glass M |
Anandamide receptor signal transduction. |
2009 |
Vitam. Horm. |
pmid:19647109
|
Brown AJ and Robin Hiley C |
Is GPR55 an anandamide receptor? |
2009 |
Vitam. Horm. |
pmid:19647110
|
Correa FG et al. |
The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis. |
2009 |
Vitam. Horm. |
pmid:19647114
|
Tóth A et al. |
Anandamide and the vanilloid receptor (TRPV1). |
2009 |
Vitam. Horm. |
pmid:19647120
|
Pasquariello N et al. |
Regulation of gene transcription and keratinocyte differentiation by anandamide. |
2009 |
Vitam. Horm. |
pmid:19647122
|
Alpini G and Demorrow S |
Changes in the endocannabinoid system may give insight into new and effective treatments for cancer. |
2009 |
Vitam. Horm. |
pmid:19647123
|
Glaser ST et al. |
Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. |
2005 Nov-Dec |
Vis. Neurosci. |
pmid:16469181
|
Cruz F |
Mechanisms involved in new therapies for overactive bladder. |
2004 |
Urology |
pmid:15013655
|
Devane WA |
New dawn of cannabinoid pharmacology. |
1994 |
Trends Pharmacol. Sci. |
pmid:8165721
|
Smart D and Jerman JC |
Anandamide: an endogenous activator of the vanilloid receptor. |
2000 |
Trends Pharmacol. Sci. |
pmid:10740287
|
Randall MD and Kendall DA |
Endocannabinoids: a new class of vasoactive substances. |
1998 |
Trends Pharmacol. Sci. |
pmid:9550942
|